Deal in Focus: ArchiMed scores 300x return for Polyplus exit
ArchiMed has bagged a 300x return with the sale of Polyplus, in an exit Preqin reported as the largest ever from a PE buyout fund.
ArchiMed has bagged a 300x return with the sale of Polyplus, in an exit Preqin reported as the largest ever from a PE buyout fund.